Related Experiment Video
Updated: Nov 23, 2025

Daily Phototherapy with Red Light to Regulate Candida albicans Biofilm Growth
Published on: April 23, 2019
A Timeline of Onychomycosis Therapy and Future Directions
Solomon Geizhals1, Shari R Lipner2
1SUNY Downstate Medical School, Brooklyn, NY.
Abstract:
Onychomycosis was first described in the mid-1800's, and early treatment regimens involved applying corrosive substances and nail plate avulsion. It was not until the mid-1900's that more specific antifungal agents were utilized. Initially, only oral drugs were used, with ciclopirox 8% solution later approved in 1999. Presently, terbinafine, itraconazole, and fluconazole (off-label) are used for systemic onychomycosis therapy in the US, and topicals include ciclopirox, efinaconazole and tavaborole. Devices, topicals with new mechanisms of action, and oral medications with potentially better efficacy are now being explored for treatment of onychomycosis.
Insights
Onychomycosis treatment has evolved from harsh methods to targeted antifungal drugs. Current research explores novel devices and medications for improved nail fungus therapies.
Area of Science:
- Dermatology
- Mycology
- Pharmacology
Background:
- Onychomycosis, a common nail fungal infection, has a long history of treatment.
- Early treatments included corrosive substances and nail avulsion.
- Antifungal agents have become more specific since the mid-1900s.
Purpose of the Study:
- To review the historical progression of onychomycosis treatment.
- To outline current therapeutic options for nail fungus.
- To highlight emerging treatment modalities.
Main Methods:
- Literature review of historical and current onychomycosis treatments.
- Analysis of approved systemic and topical antifungal agents.
- Identification of novel therapeutic approaches under investigation.
Main Results:
- Initial treatments were invasive and non-specific.
- Systemic antifungals like terbinafine and itraconazole are current mainstays.
- Topical agents include ciclopirox, efinaconazole, and tavaborole.
- Newer treatments like devices and novel drug mechanisms are in development.
Conclusions:
- Onychomycosis treatment has advanced significantly with the development of specific antifungal drugs.
- Current therapies include oral and topical agents.
- Future treatments aim for enhanced efficacy and novel mechanisms of action.
Related Concept Videos
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Psychosis: Goals of Pharmacotherapy
Drug Therapy
Antianxiety Medications
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Endocarditis III: Medical Management
Fungal Phylum Microsporidia

